We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Tyr6.0
Tyrosine Research
Mostly mechanism / observational
64 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Tyrosine studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 1984–2026 with a typical study size of 48 participants.
Based on 64 studies · 4 meta-analyses · 52 RCTs · 28,343 total participants
Confidence
High confidence
By outcome
Cognitive functionEnhances working memory under stress and cognitive load · 30-60 minutes
Guan C, Zhang R, Zhao P, Zhang Y, Yu L, Cui H, Jiang L, Wu T, Liu F, Wu Y, Huang L, Nan H, Wang J, Xu P. · Frontiers in immunology (2026)
Pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated using fixed- or random-effects models based on heterogeneity.
Meta-analysis demonstrated a significant protective effect of vaccination against COVID-19 infection (fixed-effects model: OR = 0.23, 95% CI [0.20-0.26], P < 0.001).
Conversely, vaccination was not associated with a statistically significant increase in MG exacerbation (random-effects model: OR = 0.67, 95% CI [0.10-4.54], P = 0.68).
Williamson G et al. · Critical reviews in food science and nutrition (2025)
Ca 30% of publications report bioactivity at ≤1 μmol/L.
Free-living and washout plasma data are scarce.
Some metabolites have been overlooked, notably phenyl-lactic, phenyl-hydracrylic and phenyl-propanoic acids, especially those from amino acids plus glycine, hydroxy-glycine and glutamine conjugates.
This comprehensive review explores L-DOPA's synthesis, pharmacokinetics, mechanism of action, and its evolving role in neurological diseases, while highlighting ongoing challenges and future directions for optimizing its clinical application.
Kulkarni SR et al. · Molecular and cellular biochemistry (2025)
However, long-term use is associated with challenges such as motor fluctuations, dyskinesias, and loss of therapeutic efficacy due to progressive neurodegeneration and alterations in dopaminergic pathways.
Recent advancements in drug delivery systems, combination therapies, and nanotechnology, including plant-derived carbon dots, offer promising strategies to enhance L-DOPA's effectiveness while mitigating its limitations.
This comprehensive review explores L-DOPA's synthesis, pharmacokinetics, mechanism of action, and its evolving role in neurological diseases, while highlighting ongoing challenges and future directions for optimizing its clinical application.